{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for histamine in Code Comments (approximate match)
Status:
US Approved Allergenic Extract
Source:
BLA103888
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2020)
Source URL:
First approved in 2020
Source:
21 CFR 333A
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT04160767: Phase 4 Interventional Unknown status Celiac Disease
(2019)
Source URL:
First approved in 2010
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Compound hydrolyzed protein beverage by Nanjing Zhongtiandeheng Applied Stemmedical Co., Ltd
(2024)
Source URL:
First approved in 2024
Source:
Compound hydrolyzed protein beverage by Nanjing Zhongtiandeheng Applied Stemmedical Co., Ltd
Source URL:
Class:
PROTEIN
Status:
US Approved Allergenic Extract
(1994)
Source:
BLA103738
(1994)
Source URL:
First approved in 1994
Source:
BLA103738
Source URL:
Class:
POLYMER
Status:
US Approved OTC
Source:
21 CFR 347.10(f) skin protectant colloidal oatmeal
Source URL:
First approved in 1987
Source:
M016
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02477917: Phase 1 Interventional Completed Rhinoconjunctivitis
(2015)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03630458: Not Applicable Interventional Completed Obesity
(2018)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03135015: Phase 1 Interventional Completed Insulin Resistance, Diabetes
(2017)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02189083: Phase 3 Interventional Completed Leiomyoma
(2014)
Source URL:
Class:
STRUCTURALLY DIVERSE
